Colon cancer-associated transcript 2 (CCAT2) enhances proliferation and decreases apoptosis in tamoxifen-resistant cells, and the reduction in CCAT2 provides a new approach for breast cancer patients [166]. The gene discussed is CCAT2; the disease is breast cancer.